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Abstract 
Introduction: Ketamine is an agent broadly used for pediatric procedural sedation and analgesia in emergency 
departments. It has been found to be safe and with a low risk of complications. Choosing between intravenous (IV) 
and intramuscular (IM) injections is a matter of concern, so we did a comparison between the two methods in terms 
of their efficacy and rate of complications. Methods: This single-blind clinical trial recruited 240 children (age: 
three months to 15 years, weight > 5 kg), who underwent short and painful procedures at the emergency depart-
ments. They were randomly allocated to two groups of 120 patients to receive either IV or IM ketamine with of 1.5 
and 4 mg/kg doses, respectively. Indications for use, dose, side effects, and efficacy of the medications as well as 
duration of the procedure and time to recovery were compared between the two groups. Results: The mean age of 
the IV and IM groups were 6.5 ± 3.6 and 3.05 ± 2.6 years, respectively (p < 0.001). The onset of action of ketamine 
was 1.7 ± 1.1 minutes in the IV group and 8.6 ± 3.1 in the IM ones (p < 0.001). Patients of the IV and IM groups 
remained in optimal sedation for 20.6±12.0 and 37.2±11.8 minutes, respectively (P < 0.001) .Time until emergency 
department discharge was 65.3 ± 36.9 minutes in the IV group and 72.2 ± 14.5 in the IM group (P = 0.40) .Ketamine 
had excellent and moderate efficacy in 66.7% and 32.5% of the IV group and 70.0% and 25.0%  in the IM group, 
respectively (p = 0.02). Totally, 60.0% of IV group patients and 40.0% of IM group experienced drug side effects (p 
= 0.21). Need for rescue dose was significantly higher in IV group (26.7% vs. 10.0%; p < 0.001). Finally, recovery 
was tranquil and comfortable in 88 patients (73.3%) of the IV group and 108 patients (90.0%) of the IM group (p 
= 0.06). Conclusion: We found that although the sedative and analgesic effects of IM and IV ketamine are not sig-
nificantly different, duration of effect and onset of action are more desirable in the IV group for suturing, fracture 
reduction, and foreign body removal. Meanwhile, the IM method can lead to lesser need of rescue doses. 
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Introduction: 
etamine is an antagonist receptor of N-methyl-D-
aspartate (NMDA) and phencyclidine derivate 
sedative agent broadly used for pediatric proce-
dural sedation and analgesia (PSA) in emergency depart-
ments (1-3). Rapid onset, relatively short-term effects, 
and excellent sedative and analgesic effects make it an 
appropriate choice for short and painful procedures. Nu-
merous clinical trial studies have approved ketamine as 
a desirable and safe medication with low risk of emer-
gence phenomena (4-10). Several studies in this field 
have compared two methods of intravenous (IV) and in-
tramuscular (IM) administration based on time until 
hospital discharge and the incidence rate of side effects 
(6, 11-13). However, the superiority of either IV or IM 
application of the drug has been still under debate. 
Choosing the route of administration depends on availa-
ble factors such as: emergency department facilities, pa-
tient characteristics and comfort, and physician’s expe-
rience and preference, drug’s complications and side ef-
fects, and onset and duration of drug action (12-15). 
Since few studies were done among Iranian population 
in this regard, the present study was performed to iden-
tify the preferable route for using ketamine by compar-
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Methods: 
Study design and setting 
This single-blind clinical trial was conducted on three 
months to 15 years old children that weighted more than 
5 kilograms, and required PSA for short and painful 
emergency procedures, who were presented to the 
emergency departments of Imam Reza and Hashemi-
nejad Hospitals, Mashhad, Iran. Ethics committee of 
Mashhad University of Medical Sciences confirmed the 
study protocol and researchers were committed to the 
principles of the Helsinki declaration throughout the 
study period. Before any intervention, administered 
medication and its complications were thoroughly ex-
plained for their parents and informed written consent 
was obtained from them. This trial is registered in Ira-
nian registry of clinical trial (IRCT) under number 
IRCT2014071218454N1. 
Participants  
240 children were recruited using convenience sam-
pling. They were randomly allocated in two groups of 
120 patients by using block randomization method. Sub-
jects with a history of allergy to ketamine, severe cardi-
ovascular diseases, thyroid disorders, head injury, cen-
tral nervous system (CNS) disorders, glaucoma or acute 
globe injuries, history or evidence of psychosis, obstruc-
tive sleep apnea, active pulmonary diseases such as up-
per respiratory tract infection, tracheal stenosis or sur-
gery, needed procedures associated with stimulation of 
posterior pharyngeal region, and those who were not 
willing to participate were excluded from the study.  
Intervention 
Sedation by ketamine was performed according to 
standard guidelines (14). Pulse oximetry and cardiac 
monitoring were constantly performed before, during, 
and after sedation. A nurse, blinded to the intervention, 
was present by the side of the patients during the whole 
procedure and not only recorded the routine nursing ob-
servations and evaluations, but also any abnormal con-
ditions until the patient recovered to his/her pre-proce-
dure state. Venipuncture was performed for all patients 
to ensure blindness of the nurses and physicians. The 
first group of patients received IV ketamine (1.5 mg/kg, 
Infusion by 100 milliliter normal saline; maximum dose 
200 mg), and the second took an IM dose (4 mg/kg; max-
imum dose 200 mg). Patients with an open airway and 
adequate oxygen saturation, who were awake or could 
be easily awakened with minimal stimulation, able to 
drink liquids, and returned to the baseline level of con-
sciousness were considered eligible for discharging from 
the emergency department. 
Outcomes  
The data regarding demographic characteristics, dura-
tion of the procedure, the medicine’s onset and duration 
of action, efficacy, side effects, and time until emergency 
department discharge were gathered for all participants.  
At the end of the procedure, a specialist, who was 
blinded to the intervention, rated the efficacy of medi-
cine in pain management and sedation as excellent (full 
sedation, immobility, and analgesia during the whole 
procedure), moderate (slight movements due to pain 
without interfering in the procedure), and poor (move-
ments associated with pain that interfered in the proce-
dure). The patients' status was followed for at least one 
hour in the recovery room and the incidence of any ad-
verse effects was recorded. Children with restlessness or 
hallucinations were categorized as "recovery with agita-
tion". In the absence of any side effects, the subjects were 
classified as "tranquil and comfortable". 
Statistical analysis 
The sample size calculation was performed based on de-
tection of clinically significant differences in the inci-
dence of vomiting. In a previous study, vomiting oc-
curred in 18.3% and 35.4% of patients in IV and IM 
groups, respectively (11). With considering α = 0.05 and 
80% power, 232 patients were needed to be enrolled. 
The collected data were entered to SPSS version 20.0 
(SPSS Inc., Chicago, IL, USA) and described by using 
mean and standard deviation, graphs and tables. Varia-
bles without normal distribution and ordinal ones were 
analyzed through Mann-Whitney U test. Chi-square test 
was also performed to compare qualitative variables be-
tween the two groups. For assessment of any difference 
between IV and IM groups related to efficacy, side ef-
fects, duration of the procedure, time to recovery and 
time to discharge we used generalized linear model ad-
justed for baseline characteristics.  P values less than 
0.05 were statistically considered significant.  
Results: 
 The mean age of the IV and IM groups were 6.5±3.6 and 
3.05±2.6 years, respectively (p < 0.001). 80 (66.7%) 
and 60 (50.0%) cases were male in IV and IM groups, 
respectively (p = 0.009). The mean weight of the IV and 
Table 1: Demographic characteristics of children re-






Age (years) 6.5 ± 3.6 3.05 ± 2.6 <0.001* 
Gender    
Male 80 (66.7) 60 (50.0) 
0.009# Female 40 (33.3) 60 (50.0) 
Weight (kg) 2.3 ± 13 14.2 ± 8.6 <0.001* 
Procedure     
Suturing 81(67.5) 97 (81.0) 
0.34# Fracture reduction 21(17.5) 11 (9.0) 
Foreign body removal 18 (15.0) 12 (10.0) 
Values are Number (%); *, Based on Mann-Whitney U test; #, 
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IM groups were 22.3 ± 13.0 and 14.2 ± 8.6 kilograms, 
respectively (p < 0.001). Suturing, distal radius fracture 
reduction, and foreign body removal were performed for 
178 (74.0%), 32 (13.5%), and 30 (12.5%) subjects, re-
spectively (Table 1). The onset of ketamine action was 
1.7 ± 1.1 (range: 1 - 5) minutes in the IV group and 8.6 ± 
3.1 (range: 5 - 15) in the IM group (p < 0.001). Patients 
of the IV and IM groups remained in optimal sedation for 
20.6 ± 12.0 (range: 6 - 45) and 37.2 ± 11.8 (range: 15 - 
60) minutes, respectively (p < 0.001) .Time until emer-
gency department discharge was 65.3 ± 36.9 minutes in 
the IV group and 72.2±14.5 minutes in the IM group (p = 
0.40) (Figure 1) .Ketamine had excellent and moderate 
efficacy in 66.7% and 32.5% of the IV group and 70.0% 
and 25.0%  in the IM group, respectively (p = 0.02) (Ta-
ble 2). Totally, 60.0% of IV group patients and 40.0% of 
IM experienced drug side effects. After adjustment for 
age, gender, and weight there was no statistical signifi-
cance (p = 0.21). Nausea and vomiting were observed in 
40 (33.3%) patients of the IV group and 18 (15.0%) pa-
tients of the IM ones (p = 0.21). Hallucinations were de-
tected in 16 (13.1%) and 12 (10.0%) of the IV and IM 
groups, respectively (p = 0.30). IV and IM injections of 
ketamine resulted in agitation in 24 (20.0%) and 12 
(10.0%) patients, respectively (p = 0.88). The frequency 
of respiratory depression was eight (6.8%) and 18 
(15.0%) in the IV and IM groups, respectively (p = 0.29). 
Need to rescue dose was significantly higher in IV group 
(26.7% vs. 10.0%; p < 0.001) (Table 2). Finally, the re-
covery was tranquil and comfortable in 88 patients 
(73.3%) of the IV group and 108 patients (90.0%) of the 
IM group (p = 0.06). 
Discussion: 
The results of the present study showed that although 
the sedative and analgesic effects of IM and IV ketamine 
were not significantly different, duration of effect and 
onset of action were more desirable in the IV group for 
suturing, fracture reduction, and foreign body removal. 
Meanwhile, the IM method led to fewer need to rescue 
doses. In general, because of no difference in side effects 
and recovery time between IV and IM methods, it was 
suggested that IV infusion of ketamine might be safer 
and more effective than IM injection for PSA.  
In 2006, Roback et al. compared the side effects, efficacy, 
and duration of sedation induced by IV and IM injection 
of ketamine in patients required orthopedic procedures. 
While respiratory complications in the two groups were 
similar (8.3% in the IV group vs. 4.0% in the IM group), 
the frequency of vomiting was higher in the IM group 
(26.3% vs. 11.9%). Moreover, the IM administration of 
ketamine was associated with significantly lower levels 
of pain and higher duration of sedation compared to the 
IV route. The researchers concluded that although IM in-
jection of ketamine had better sedative properties com-
pared to IV application, it was clearly accompanied by 
longer recovery and more vomiting (11). In spite of sim-
ilar methodology, the findings of Roback et al. were in 
contrast with ours. The mean onset of action was 1.67 
minutes in the IV group and 8.65 minutes in the IM 
group. In addition, mean time until emergency depart-
ment discharge was 65.33 and 72.25 minutes in the 
above-mentioned groups, respectively. Consequently, 
the IV method was more favorable based on both speed 
of onset of action and time spent in the emergency de-
partment. Since the efficacy difference between the two 
Table 2: Outcome of children receiving intravenous (IV) or intramuscular (IM) ketamine 
Factor 
Group 
Odds ratio 95% CI p* 
IV IM 
Efficacy      
Excellent 80 (66.7) 84 (70.0) Ref Ref  
Moderate 39 (32.5) 30 (25.0) 1.5 0.8 - 3.0 0.24 
Poor 1 (0.8) 6 (5.0) 0.4 0.05 - 3.4 0.19 
Need to rescue dose      
No 88 (73.3) 108 (90) Ref Ref  
Yes 32 (26.7) 12 (10.0) 5.8 2.5 -13.6 <0.001 
Recovery      
Tranquil and comfortable 88 (73.3) 108 (90.0) Ref Ref  
Brief agitation 32 (26.7) 12 (10.0) 2.0 0.9 - 4.8 0.06 
Side effects      
No side effects  48 (40.0) 72 (60.0) Ref Ref  
Nausea and vomiting 40 (33.3) 18 (15.0) 1.6 0.8 - 3.5 0.21 
Hallucination 16 (33.3) 12 (10.0) 1.7 0.6 - 4.2 0.30 
Agitation 24 (20.0) 12 (10.0) 1.1 0.4 - 2.7 0.88 
Respiratory depression 8 (6.7) 18 (15.0) 0.5 0.1 - 1.8 0.29 
Total 72 (60.0) 48 (40.0) 1.5 0.8 - 2.7 0.21 
Values are Number (%); *, Based on generalized linear model adjusted for age, gender, and weight of patients; CI = confidence 
interval; Ref = reference category 
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groups was not significant, no route of administration 
was favorable in terms of effectiveness (i.e. those causing 
optimal sedation and analgesia) .In evaluation of the side 
effects, we did not detect any significant difference be-
tween groups. Unlike our findings, Roback et al. sug-
gested this side effect to be more frequent following IM 
injections (11). In addition, in Ramaswamy et al. study 
side effects were seen in 35% of the IM group and 20% 
of the IV group. Moreover, time until discharge after the 
injection was 21 minutes shorter in the IV group. How-
ever, time from the beginning of triage until discharging 
was similar in two groups. The time required for cathe-
terization in the IV method was suggested to be respon-
sible for such findings (13). Nevertheless, as we did not 
consider the time required for venipuncture, similar re-
sults were obtained regarding time until discharge. In a 
review study in 2010, Deasy et al. reported that IV keta-
mine injections were generally associated with fewer 
side effects and shorter duration of action compared to 
IM administration of the medicine. They concluded that 
when it is performed by a skilled person, the IV method 
could induce sedation more effectively than the IM 
method (16). Another review study by Green et al. in 
2006 indicated shorter time until discharge and less ef-
ficacy following the IV injections of ketamine. However, 
the researchers state that selecting the best route of ad-
ministration depends on the physician’s decision based 
on the conditions and facilities of the hospital, particu-
larly the emergency department and skillfulness of the 
staff (12). As the two groups in the current study had no 
significant difference in terms of efficacy, we recom-
mend the same criteria for selecting the appropriate 
method. On the other hand, racial and environmental 
factors might have influenced on the effectiveness and 
side effects of the medicine, too.  
The present study contained some limitations. Because 
of difference in the method of administration, there was 
no possibility to blind the patient to the intervention, so 
the study was done as single-blind fashion. Furthermore, 
although the person who gathered the data was not in-
formed about the injection method, he might be aware of 
the group that underwent therapy during clinical assess-
ments. Thus, it could be possible to influence the blind-
ness of the observer in some cases. To avoid such a prob-
lem, the observer was trained not to ask anything from 
the patient regarding therapeutic interventions. 
Conclusion: 
It was found that although the sedative and analgesic ef-
fects of IM and IV ketamine were not significantly differ-
ent, duration of effect and onset of action were more de-
sirable in the IV group for suturing, fracture reduction, 
and foreign body removal. Meanwhile, using the IM 
method can lead to lesser need for rescue doses. 
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